CDK4 and cancer: Second, a more complex cancer-case study expanded to all central carbon metabolism, associated with a set of experimental measurements obtained in cultured human colon cancer cells (HCT116) following the inhibition of cyclin-dependent kinases 4 and 6 (CDK4/6) [50].